United States· US:0065-9305_99e11df4-015e-41eb-804d-85a3e0e6c5be
BION TEARS
A medicinal product containing dextran 70; hypromellose 2910 (4000 mpa.s), registered in United States by Alcon Laboratories, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DEXTRAN 70; HYPROMELLOSE 2910 (4000 MPA.S)
- Manufacturer
- Alcon Laboratories, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11006593050128 VIAL in 1 CARTON (0065-9305-01) / .4 mL in 1 VIAL
- ndc110065-9305-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f1e24b18-1a9a-400c-a28c-9d79a4cf2114 GET /v1/drugs/f1e24b18-1a9a-400c-a28c-9d79a4cf2114?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "OPHTHALMIC",
"source": "ndc",
"strength": "1; 3",
"substance": "DEXTRAN 70; HYPROMELLOSE 2910 (4000 MPA.S)",
"productndc": "0065-9305",
"dosage_form": "SOLUTION/ DROPS",
"dea_schedule": null,
"strength_unit": "mg/mL; mg/mL",
"application_number": "M018",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about dextran 70; hypromellose 2910 (4000 mpa.s).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.